1 November 2018

Wikimedia Commons The Radboud Biobank has added a new sub-biobank to the collection: the Haemophilia Pearl which is part of the Parelsnoer Institute

The Radboud Biobank has added a new sub-biobank to the collection: the Haemophilia Pearl which is part of the Parelsnoer Institute.The Haemophilia Pearl aims to improve the standard of haemophilia care by collecting and storing clinical data and biospecimens from Dutch haemophilia patients for future research purposes. The biospecimens and clinical data can be used to evaluate diagnostics and treatment methods and assess factors that can predict or modify the clinical course of the disease. Data and biospecimens for the Haemophilia Pearl will also be collected during the Haemophilia in The Netherlands-6 (HiN-6) project. All Dutch Haemophilia treatment centres and the Dutch Haemophilia Patient Society take part in the Haemophilia Pearl.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


Farewell Dorine Swinkels

1 September 2026

On Friday, September 4th, 2026, Dorine Swinkels will retire as Professor of Experimental Clinical Chemistry at Radboudumc. She is also leaving the Radboud Biobank.

go to page

Greening Radboud Biobank – reduction number of aliquots in storage for future initiatives

1 September 2026

Like LUMC and NKI, the Radboud Biobank will also store fewer aliquots per collection tube.

go to page

Effect of Fit & Funding on external invoices

1 September 2026

The Radboud Biobank not only manages issuances and projects for Radboudumc but also provides external services. The Radboud Biobank invoices the external organization for these services.

go to page

New link between iLES and Castor EDC connects clinical data and biobank material

1 September 2026

The Biobank Information Management System, iLES, is now linked to Castor EDC. This development was realized within a KWF-funded project.

go to page

Radboud Biobank's 2025 annual report

3 March 2026

The Radboud Biobank's 2025 annual report is now available on request.

go to page

Aevai Health developed a virtual assistant

3 March 2026

Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.

go to page